Serum resistin and adiponectin levels in women with polycystic ovary syndrome

Gynecological Endocrinology

Volumn 25, Issue 4, 2009, Pages 246-252

  Yilmaz, Murat ^a   Bukan, Neslihan ^b   Demirc, Hüseyin ^b   Öztürk, Çiǧdem ^b   Kan, Erdal ^b   Ayvaz, Göksun ^b   Arslan, Metin ^b  

^a KIRIKKALE UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

Author keywords

Adiponectin; Insulin resistance; Obesity; PCOS; Resistin

Indexed keywords

ADIPONECTIN; ANDROSTENEDIONE; FOLLITROPIN; GLUCOSE; HYDROXYPROGESTERONE; INSULIN; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; PRASTERONE SULFATE; RESISTIN; TESTOSTERONE; ADIPONECTIN, HUMAN; RETN PROTEIN, HUMAN;

ADULT; ARTICLE; BODY MASS; CARBOHYDRATE METABOLISM; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HIRSUTISM; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; OBESITY; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PRIORITY JOURNAL; BLOOD; METABOLISM; PHYSIOLOGY;

ADIPONECTIN; ADULT; BODY MASS INDEX; FEMALE; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; LIPIDS; OBESITY; POLYCYSTIC OVARY SYNDROME; RESISTIN; YOUNG ADULT;

EID: 67650317800     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590802653833     Document Type: Article

References (42)

1. Homburg R. What is polycystic ovarian syndrome? Human Reprod 2003;17:2495-2499.
2. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrinol Rev 1997;18:774-800.
3. Ehrman DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women polycystic ovary syndrome. Diabetes Care 1999;22:141-146.
4. Legro RS. Polycystic ovary syndrome and cardiovascular disease: a premature association. Endocrinol Rev 2003; 24:302-312.
5. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004;89:2548-2556.
6. Kim KH, Lee K, Soo Y, Moon YS, Sul HS. A cysteine-rich adipocyte tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem 2001;276:1152-1156.
7. Steppan CM, Lazar MA. Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab 2002;13:18-22.
8. McTernan CL, McTernan PG, Chetty R, Jenner K, Fisher FM, Lauer MN, Crocker J, Barnett AH, Kumar S. Increased resistin gene and protein expression in human adiposal tissue. J Clin Endocrinol Metab 2002;87:2407.
9. Wang H, Chu WS, Hemphill C, Elbein SC. Human resistin gene molecular scanning and evaluation of association with insulin sensitivity and type 2 diabetes in Caucasians. J Clin Endocrinol Metab 2002;87:2520-2524.
10. Kok-Min S, Chi-Chang J, Liang-Yi W, Yung-Pei H, Wei-Ming Y, Yieh-Loong T, Jiann-Loung H, Low-Tone H. Serum and adipocyte resistin in polycystic ovary syndrome with insulin resistance. Human Reprod 2004;19:48-53.
11. Panidis D, Koliakos G, Kourtis A, Farmakiotis D, Mouslech T, Rousso D. Serum resistin levels in women with polycystic ovary syndrome. Human Reprod 2004;19:48-53.
12. Escobar-Morreale HF, Villuendas G, Botella-Carretero JI, Alvarez-Blasco F, Sanchon R, Luque-Ramirez M, San Millan JL. Adiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study. Hum Reprod 2006;21:2257-2265.
13. Carmina E, Orio F, Palomba S, Longo RA, Cascella T, Colao A, Lombardi G, Rini GB, Lobo RA. Endothelial dysfunction in PCOS: role of obesity and adipose hormones. Am J Med 2006;119:1-6.
14. Lewandowski KC, Szosland K, O'Callaghan C, Tan BK, Randeva HS, Lewinski A. Adiponectin and resistin serum levels in women with polycystic ovary syndrome during oral glucose tolerance test: a significant reciprocal correlation between adiponectin and resistin independent of insulin resistance indices. Mol Genet Metab 2005;85:61-69.
15. Carmina E, Orio F, Palomba S, Cascella T, Longo RA, Colao AM, Lombardi G, Lobo RA. Evidence for altered adipocyte function in polycystic ovary syndrome. Eur J Endocrinol 2005; 152:389-394.
16. Munir I, Yen HW, Baruth T, Tarkowski R, Azziz R, Magoffin DA, Jakimiuk AJ. Resistin stimulation of 17α-hydroxylase activity in ovarian theca cells in vitro: relevance to polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:4852-4857.
17. Urbanek M, Yangzhu D, Silander K, Collins FC, Steppan CM, Strauss JF III, Dunaif A, Spielman RC, Legro RC. Variation in resistin gene promoter not associated with polycystic ovary syndrome. Diabetes 2003;52:214-217.
18. Stefan N, Vozarova B, Funahashi T, Matsuzawa Y, Weyer C, Lindsay RS, Youngren JF, Havel PJ, Pratley RE, Bogardus C. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 2002;51:1884-1888.
19. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocrinol Rev 2005;26:439-451.
20. Gulcelik NE, Aral Y, Serter R, Demir Y, Culha C. Adiponectin is an independent determinant of insulin resistance in women with polycystic ovary syndrome. Gynecol Endocrinol 2006;22:511-515.
21. Spranger J, Möhlig M, Wegewitz U, Ristow M, Pfeiffer AF, Schill T, Schlösser HW, Brabant G, Schöfl C. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 2004; 61:738-746.
22. Ardawi MS, Rouzi AA. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome. Fertil Steril 2005;83:1708-1716.
23. Glintborg D, Frystyk J, Højlund K, Andersen KK, Henriksen JE, Hermann AP, Hagen C, Flyvbjerg A, Andersen M. Total and high molecular weight (HMW) adiponectin levels and measures of glucose and lipid metabolism following pioglita-zone treatment in a randomized placebo-controlled study in polycystic ovary syndrome. Clin Endocrinol (Oxf) 2008;68: 165-174.
24. Glintborg D, Andersen M, Hagen C, Frystyk J, Hulstrøm V, Flyvbjerg A, Hermann AP. Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls. Eur J Endocrinol 2006;155:337-345.
25. Orio F Jr, Palomba S, Cascella T, Di Biase S, Labella D, Russo T, Savastano S, Zullo F, Colao A, Vettor R, et al. Lack of an association between peroxisome proliferator-activated receptor-γ gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome. J Clin Endocrinol Metab 2004;89:5110-5115.
26. Panidis D, Kourtis A, Kukuvitis A, Farmakiotis D, Xita N, Georgiou I, Tsatsoulis A. Association of the T45G polymorphism in exon 2 of the adiponectin gene with polycystic ovary syndrome: role of d4-androstenedione. Human Reprod 2004;19:1728-1733.
27. Vrbíková J, Dvoráková K, Hill M, Vcelák J, Stanická S, Vanková M, Srámková D, Vondra K, Bendlová B, Stárka L. Determinants of circulating adiponectin in women with polycystic ovary syndrome Gynecol Obstet Invest. 2005;60:155-161.
28. Sepilian V, Nagamani M. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance. J Soc Gynecol Investig 2005;12:129-134.
29. Sieminska L, Marek B, Kos-Kudla B, Niedziolka D, Kajdaniuk D, Nowak M, Glogowska-Szelag J. Serum adipo-nectin in women with polycystic ovarian syndrome and its relation to clinical, metabolic and endocrine parameters. J Endocrinol Invest 2004;27:528-534.
30. Bik W, Baranowska-Bik A, Wolinska-Witort E, Chmielowska M, Martynska L, Baranowska B. The relationship between metabolic status and levels of adiponectin and ghrelin in lean women with polycystic ovary syndrome. Gynecol Endocrinol 2007;23:325-331.
31. The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41-47.
32. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26:3160-3167.
33. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
34. Vidal-Puig A, O'Rahilly S. Resistin: a new link between obesity and insulin resistance? Clin Endocrinol (Oxf) 2003;55: 437-438.
35. McTernan CL, McTernan PG, Harte AL, Levick PL, Barnett AH, Kumar S. Resistin, central obesity, and type 2 diabetes. Lancet 2002;359:46-47.
36. Lee JH, Chan JL, Yiannakouris N, Kontogianni M, Estrada E, Seip R, Orlova C, Mantzoros CS. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab 2003;88:4848-4856.
37. Levy JR, Davenport B, Clore JN, Stevens W. Lipid metabolism and resistin gene expression in insulin-resistant Fischer 344 rats. Am J Physiol Endocrinol Metab 2002;282:E623-E626.
38. Janke J, Engeli S, Gorzelniak K, Luft FC, Sharma M. Resistin gene expression in human adipocytes is not related to insulin resistance. Obes Res 2002;10:1-5.
39. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA. The hormone resistin links obesity to diabetes. Nature 2001; 409:307-312.
40. Komatsu M, Ohfusa H, Aizawa T, Hashizume K. Adiponectin inversely correlates with high sensitive C-reactive protein and triglycerides, but not with insulin sensitivity, in apparently healthy Japanese men. Endocrinol J 2007;54:553-558.
41. Koh KK, Quon MJ, Han SH, Lee Y, Ahn JY, Kim SJ, Koh Y, Shin EK. Simvastatin improves flow-mediated dilation but reduces adiponectin levels and insulin sensitivity in hypercholesterolemic patients. Diabetes Care 2008;31: 776-782.
42. Farvid MS, Ng TW, Chan DC, Barrett PH, Watts GF. Association of adiponectin and resistin with adipose tissue compartments, insulin resistance and dyslipidaemia. Diabetes Obes Metab 2005;7:406-413.